| STAAR SURGICAL CO. DL-,01 |
| USA |
| Gesundheit |
| US8523123052 / 870353 |
| SR3 (Frankfurt) / STAA (NASDAQ) |
| FRA:SR3, ETR:SR3, SR3:GR, NASDAQ:STAA |
| - |
| https://staar.com/ |
|
Staar Surgical Company designs, develops, manufactures, and sells implantable lenses for eye surgery, operating primarily in the ophthalmic medical devices sector. The company offers two main product categories: Implantable Collamer lenses (ICL) used..
>Volltext.. |
| 829.13 Mio. EUR |
| 702.17 Mio. EUR |
| 207.43 Mio. EUR |
| -34.73 Mio. EUR |
| -69.69 Mio. EUR |
| -1.41 EUR |
| 33.23 Mio. EUR |
| 132.68 Mio. EUR |
| -29.65 Mio. EUR |
| 2.74 |
| -32.77% |
| -250.89% |
| - |
| - |
| - |
| STAAR SURGICAL |
| 04.04.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|